Archive

Welcome to our Newsletter Archive

Here, you can access all of our previous newsletters and stay up to date with all the latest news, events, and updates from our organization. Our newsletters are filled with valuable information and insights, and we are committed to making sure that you never miss a beat. Whether you are a current subscriber or just exploring what we have to offer, our Newsletter Archive page is the perfect resource for staying connected with us.

In each newsletter, you will find a variety of content, including articles, infographics, videos, and more. Our team of experts works hard to curate the most relevant and valuable information for our subscribers, and we are always looking for new and innovative ways to share that information with you.

Recent archive

Deuterated Enzalutamide & its related compounds

Apr 2023

At Clearsynth, we understand you are working on Enzalutamide and we are here to help you by supplying the products you require for the research. Please contact us for more details.

Working on a Sulfonylurea Drug? Glimepiride

Mar 2023

Glimepiride is a sulfonylurea class of drug approved by the FDA in 1995. It is one of the top ten medications for diabetes.

Reference Standards of Famotidine

Mar 2023

Did you know that Clearsynth is second-to-none in the production of famotidine and its related compounds?

Stable Isotopes & Impurities Of Clopidogrel

Mar 2023

Working on Clopidogrel? It is a vital antiplatelet medication used to prevent blood clots in patients with heart and blood vessel conditions. It works by helping to keep blood platelets from sticking together and forming clots.

Ritonavir & its related compounds

Mar 2023

Ritonavir is an antiretroviral drug, it is most commonly used as a pharmacokinetic enhancer, in order to increase the plasma concentrations of other antiretrovirals.

Rifampicin & its related compounds

Feb 2023

Rifampicin is a very powerful bacteriostatic and bactericidal macrocyclic antibiotic that is predominantly utilised as one of the most significant and potent components of first-line tuberculosis therapy (TB).